IRRITABLE BOWEL SYNDROME IS A RISK FACTOR FOR GLAUCOMA; ANALYSIS OF TWO EUROPEAN POPULATION-BASED COHORT STUDIES
PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM
RANDOMISED, OPEN-LABEL STUDY TO EVALUATE 2 INTRAVITREAL AFLIBERCEPT TREAT-AND-EXTEND DOSING REGIMENS IN WET AGE-RELATED MACULAR DEGENERATION: 52-WEEK OUTCOMES FROM ALTAIR
N-ACETYL-CYSTEINE IN OCULAR THERAPY: A REVIEW OF THE LITERATURE
EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES
THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA